Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 4, 2008, Pages

  Wen, Yeshao ^a   Gu, Jiali ^a   Vandenhoff, George E ^a   Liu, Xiaoping ^a   Nadler, Jerry L ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NONE   (United States)

Author keywords

12 15 lipoxygenase; J774A.1 cells; Monocyte chemoattractant protein 1; Mouse peritoneal macrophages

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; APOCYNIN; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; DIPHENYLIODONIUM SALT; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY INFILTRATE; INTRAABDOMINAL FAT; KNOCKOUT MOUSE; MACROPHAGE; MALE; MONOCYTE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TRANSGENIC MOUSE; UPREGULATION;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; ACETOPHENONES; ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; CELL LINE; CHEMOKINE CCL2; ENZYME ACTIVATION; HYDROXYEICOSATETRAENOIC ACIDS; IMIDAZOLES; INDOLES; MACROPHAGES; MALE; MALEIMIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NADPH OXIDASE; NAPHTHALENES; ONIUM COMPOUNDS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PYRIDINES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION; UP-REGULATION;

EID: 41749097860     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00260.2007     Document Type: Article

References (33)

1. Cathcard MK, Folcik VA. Lipoxygenase and atherosclerosis: Protection versus pathogenesis. Free Rad Biol Med 28: 1726-1734, 2000.
2. Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease. Circ Res 95: 858-866, 2004.
3. kB). J Mol Cell Cardiol 36: 585-595, 2004.
4. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: application to quantify cytokine gene expression. Methods 25: 386-401, 2001.
5. Haslinger B, Mandle-Weber S, Sellmayer A, Lederer SR, Sitter T. Effect of high glucose concentration on the synthesis of monocyte- chemoattractant protein-1 in human peritoneal mesothelial cells, Involvement of protein kinase C. Nephron 87: 346-351, 2001.
6. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a casual role in multiple forms of insulin resistance. Nature 440: 944-948, 2006.
7. Huo Y, Zhao L, Hyman MC, Shashkin P, Harry BL, Burcin T, Forlow SB, Stark MA, Smith DF, Clarke S, Srinivasan S, Hedrick CC, Pratico D, Witztum JL, Nadler JL, Funk CD, Ley K. Critical role of macrophage 12/15-lipoxygenase for antherosclerosis in apolipoprotein E-deficient mice. Circulation 110: 2024-2031, 2004.
8. Kaminski KA, Bonda TA, Korecki J, Musial WJ. Oxidative stress and neutrophil activation-the two keystones of ischemia/reperfusion injury. Int J Cardiol 86: 41-59, 2002.
9. Kim YS, Reddy MA, Lanting L, Adler SG, Natarajan R. Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice. Internat Society Nephrol 64: 1702-1714, 2003.
10. Li SL, Reddy MA, Qiangiun C, Li M, Hang Y, Lanting L, Natarajan R. Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice. Diabetes 55: 2611-2619, 2006.
11. Libby P. Inflammation in atherosclerosis. Nature 420: 686-674, 2002.
12. ΔΔCT method. Methods 25: 402-408, 2001.
13. Meyer ME, Schmitt J. A central role for the endothelial NADPH oxidase in atherosclerosis. FEBS Lett: 472: 1-4, 2000.
14. Natarajan R, Lanting L, Xu L, Nadler JL. Role of specific isoforms of protein kinase C in angiotensin II and lipoxygenase action in rat adrenal glomerulosa cells. Mol Cell Endocrinol 101: 59-66, 1994.
15. Natarajan R, Nadler JL. Lipid inflammatory mediators in diabetic vascular disease. Arterioscler Thromb Vasc Biol 24: 1542-1548, 2004.
16. Natarajan R, Reddy MA, Malik KU, Fatima S, Kahn BV. Signaling mechanisms of nuclear factor-kappab-mediated activation of inflammatory genes by 13 hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells. Aterioscler Thromb Vasc Biol 21: 1408-1413, 2001.
17. Neels JG, Olefsky JM. Inflamed fat: what starts the fire? J Clin Invest 116: 33-35, 2006.
18. Patricia MK, Natarajan R, Dooley AN, Hernandez F, Gu J, Berliner JA, Rossi JJ, Nadler JL, Meidell RS, Hedrick CC. Adenoviral deliver of leukocyte-type 12-lipoxygenase adenoviral delivery of leukocyte-type 12-lipoxygenase ribozyme inhibits effects of glucose and platelet-derived growth factor in vascular endothelial and smooth muscle cells. Circ Res 88: 659-665, 2001.
19. Qin F, Patel R, Yan C, Liu W. NADPH oxidase is involved in angiotensin II-induced apoptosis in H9C2 cardiac muscle cells: effects of apocynin. Free Rad Med 40: 236-246, 2006.
20. Reape TJ, Groot PHE. Chemokines and atherosclerosis. Atheroscleosis 147: 213-225, 1999.
21. Reddy RG, Yoshimoto T, Yamamoto S, Funk CD, Marnett LJ. Expression of pocine leukocyte 12-lipoxygenase in baculovirus/insect cell system and its characterization. Arch Biochem Biophys 312: 219-226, 1994.
22. Reilly KB, Srinivasan S, Hatley ME, Patricia MK, Lannigan J, Bolick DT, Vandenhoff G, Pei H, Natarajan R, Nadler JL, Hedrick CC. 12/15-Lipoxygenase activity mediates inflammatory monocyte/endothelial interactions and atherosclerosis in vivo. J Biol Chem 279: 9440-9450, 2004.
23. Roy P, Roy SK, Mirtra A, Kulkarni AP. Superoxide generation by lipoxygenase in the presence of NADH and NADPH. Biochem Biophys Acta 1214: 1171-1179, 1994.
24. Sakashita T, Takahashi Y, Kinoshita T, Yoshimoto T. Essential involvement of 12-lipoxygenase in regiospecific and stereospecific oxidation of low density lipoprotein by macrophages. Eur J Biochem 265: 825-831, 1999.
25. Sun D, Funk C. Disruption of 12/15-Lipoxygenase expression in peritoneal macrophages. J Biol Chem 271: 24055-24062, 1996.
26. Toichi E, Torres G, McCormick TS, Chang T, Mascelli MA, Kauffman CL, Aria N, Gottlieb AB, Everitt DE, Frederick B, Pendley CE, Cooper KD. An anti-IL012p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis. J Immunol 177: 4917-4926, 2006.
27. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel R, Ferrante AW. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 115: 115-124, 2006.
28. Wen Y, Gu J, Chakrabarti SK, Aylor K, Marshall J, Takahashi Y, Yoshimoto T, Nadler JL. The role of 12/15-lipoxygenase in the expression of IL-6 and TNF-α in macrophages. Endocrinology 148: 1313-1322, 2007.
29. Wen Y, Gu J, Peng X, Zhang G, Nadler JL. Overexpression of 12-lipoxygenase and cardiac fibroblast hypertrophy. Trends Cardiovasc Med 13: 129-136, 2003.
30. Wen Y, Gu J, Liu Y, Wang PH, Sun Y, Nadler JL. Overexpression of 12-lipoxygenase causes cardiac fibroblast cell growth. Cir Res 88: 70-76, 2001.
31. Yla-Herttuala S. Oxidized LDL and atherogenesis. Ann NY Acad Sci 874: 134-137, 1999.
32. Yoshimoto T, Takahashi Arachidonate 12-lipoxygenases Y. Prostaglandins and other lipid Mediators. 68-69: 245-262, 2002.
33. Zhu H, Takahashi Y, Xu W, Kawajiri H, Murakami T, Yamamoto M, Iseki S, Iwasaki T, Hattori T, Hattori H, Yosjimoto T. Low density lipoprotein receptor-related protein-mediated membrane translocation of 12/15-lipoxygenase is required for oxidation of low density lipoprotein by macrophages. J Biol Chem 278: 13350-13355, 2003.